Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction.
Elife. 2024 Apr 2;12:RP90532. doi: 10.7554/eLife.90532.
Elife. 2024.
PMID: 38564252
Free PMC article.
Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses.
D'Alise AM, Leoni G, Cotugno G, Siani L, Vitale R, Ruzza V, Garzia I, Antonucci L, Micarelli E, Venafra V, Gogov S, Capone A, Runswick S, Martin-Liberal J, Calvo E, Moreno V, Symeonides SN, Scarselli E, Bechter O.
D'Alise AM, et al. Among authors: venafra v.
Clin Cancer Res. 2024 Mar 20. doi: 10.1158/1078-0432.CCR-23-3940. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38506710
Item in Clipboard
Impact of FLT3-ITD location on cytarabine sensitivity in AML: a network-based approach.
Pugliese GM, Venafra V, Bica V, Massacci G, Latini S, Graziosi S, Fischer T, Mougiakakos D, Boettcher M, Perfetto L, Sacco F.
Pugliese GM, et al. Among authors: venafra v.
Leukemia. 2023 May;37(5):1151-1155. doi: 10.1038/s41375-023-01881-5. Epub 2023 Mar 25.
Leukemia. 2023.
PMID: 36966261
Free PMC article.
No abstract available.
Item in Clipboard
A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patients.
Massacci G, Venafra V, Latini S, Bica V, Pugliese GM, Graziosi S, Klingelhuber F, Krahmer N, Fischer T, Mougiakakos D, Boettcher M, Perfetto L, Sacco F.
Massacci G, et al. Among authors: venafra v.
Leukemia. 2023 Feb;37(2):288-297. doi: 10.1038/s41375-022-01785-w. Epub 2022 Dec 12.
Leukemia. 2023.
PMID: 36509894
Free PMC article.
Item in Clipboard
Cite
Cite